CXCR3 and neoplasm: Through inhibiting MMPs such as MMP-9, MMST can recruit CXCR3-positive T cells to focus on tumor due to the increased chemokines in the TME, and then exhibit a synergistic effect with chemotherapeutics such as PTX to achieve chemoimmunotherapy.